Literature DB >> 34137251

Nanostructured Non-Newtonian Drug Delivery Barrier Prevents Postoperative Intrapericardial Adhesions.

Xichi Wang1,2,3,4, Zongtao Liu4, Diego A Sandoval-Salaiza1,2,3,5, Samson Afewerki1,2,6, Mildred G Jimenez-Rodriguez1,2,3,5, Lorena Sanchez-Melgar1,2,3,5, Gabriela Güemes-Aguilar1,2,3,7, David G Gonzalez-Sanchez1,2,3,7, Oscar Noble1,2,3,7, Cecilia Lerma1,2,3,5, Roberto Parra-Saldivar1,2,5, Dario R Lemos1,3, Guillermo A Llamas-Esperon8, Jiawei Shi4, Li Li3, Anderson O Lobo9, Andres A Fuentes-Baldemar1,2,3, Joseph V Bonventre1,2,3, Nianguo Dong4, Guillermo U Ruiz-Esparza1,2,3.   

Abstract

With the increasing volume of cardiovascular surgeries and the rising adoption rate of new methodologies that serve as a bridge to cardiac transplantation and that require multiple surgical interventions, the formation of postoperative intrapericardial adhesions has become a challenging problem that limits future surgical procedures, causes serious complications, and increases medical costs. To prevent this pathology, we developed a nanotechnology-based self-healing drug delivery hydrogel barrier composed of silicate nanodisks and polyethylene glycol with the ability to coat the epicardial surface of the heart without friction and locally deliver dexamethasone, an anti-inflammatory drug. After the fabrication of the hydrogel, mechanical characterization and responses to shear, strain, and recovery were analyzed, confirming its shear-thinning and self-healing properties. This behavior allowed its facile injection (5.75 ± 0.15 to 22.01 ± 0.95 N) and subsequent mechanical recovery. The encapsulation of dexamethasone within the hydrogel system was confirmed by 1H NMR, and controlled release for 5 days was observed. In vitro, limited cellular adhesion to the hydrogel surface was achieved, and its anti-inflammatory properties were confirmed, as downregulation of ICAM-1 and VCAM-1 was observed in TNF-α activated endothelial cells. In vivo, 1 week after administration of the hydrogel to a rabbit model of intrapericardial injury, superior efficacy was observed when compared to a commercial adhesion barrier, as histological and immunohistochemical examination revealed reduced adhesion formation and minimal immune infiltration of CD3+ lymphocytes and CD68+ macrophages, as well as NF-κβ downregulation. We presented a novel nanostructured drug delivery hydrogel system with unique mechanical and biological properties that act synergistically to prevent cellular infiltration while providing local immunomodulation to protect the intrapericardial space after a surgical intervention.

Entities:  

Keywords:  controlled drug release; nanomedicine; nanotechnology; postoperative intrapericardial adhesions; self-healing hydrogel

Mesh:

Substances:

Year:  2021        PMID: 34137251     DOI: 10.1021/acsami.0c20084

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

Review 1.  Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues.

Authors:  Lin-Cui Da; Yan Sun; Yun-Hong Lin; Su-Zhu Chen; Gang-Xin Chen; Bei-Hong Zheng; Sheng-Rong Du
Journal:  Pharmaceutics       Date:  2022-08-17       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.